Using Stimulants to Treat ADHD-Related Emotional Lability
Open accessAbstract
Emotional lability, or sudden strong shifts in emotion, commonly occurs in youth with attention-deficit/hyperactivity disorder. Although these symptoms are impairing and disruptive, relatively little research has addressed their treatment, likely due to the difficulty of reliable and valid assessment. Promising signals for symptom improvement have come from recent studies using stimulants in adults, children and adolescents. Similarly, neuroimaging studies have begun to identify neurobiological mechanisms underlying stimulants' impact on emotion regulation capacities. Here, we review these recent clinical and neuroimaging findings, as well as neurocognitive models for emotional lability in ADHD, issues of relevance to prescribers and the important role of psychiatric comorbidity with treatment choices.
AI snapshot
Written from the paper’s full text.
TL;DR
This narrative review synthesizes evidence that stimulants can reduce ADHD-related emotional lability in adults and youth, though effect sizes are generally smaller than for core ADHD symptoms. It also reviews competing neurobiological models and highlights unresolved issues in assessment, pediatric replication, and treatment of refractory or comorbid cases.
Key findings
- Emotional lability is common in ADHD: parent-reported impairing levels were found in 38% of 5,326 children with ADHD, 40–49% in another clinical sample, and in 1,186 children, 25% had severe and an additional 50% had moderate emotional lability.
- In the largest adult trial, 363 adults with ADHD treated with extended-release methylphenidate for 24 weeks showed significant reduction in emotional lability, with effect sizes of 0.28–0.4, lower than stimulant effects on diagnostic ADHD symptoms (meta-analytic range 0.6–0.8); other adult methylphenidate trials reported effect sizes up to 0.7.
- In youth, lisdexamfetamine improved emotional lability in 283 children with ADHD and high emotional lability, and methylphenidate in 75 boys over a 12-week crossover trial reduced emotional lability with parent effect sizes of 0.42–0.46 and teacher effect sizes of 0.45–0.79.
- Comorbid anxiety occurs in 20–40% of youth with ADHD; older studies suggested reduced stimulant response for core ADHD symptoms in ADHD+anxiety, but the MTA trial of 579 children found equally positive MPH response, with a more pronounced response when MPH was combined with behavioral intervention.
Methods
- Design: narrative review of clinical and neuroimaging literature on emotional lability in ADHD and stimulant treatment; no systematic search or meta-analysis is described.
- Data: five randomized, double-blind, placebo-controlled trials of stimulant treatment in children or adults with ADHD in which emotional lability or a similar construct was an outcome, plus neuroimaging and comorbidity studies.
- Analysis: qualitative synthesis of clinical and neurobiological findings; no new primary data are reported.
Limitations
- The authors state that empirical support for stimulant effects on emotional lability is less robust than for diagnostic ADHD symptoms, partly due to lack of reliable and valid assessment instruments.
- The authors state that further replication is needed, particularly in pediatric samples, along with larger samples, placebo-controlled longitudinal designs, and studies of stimulant-refractory emotional lability and comorbidity mechanisms.
- Evident from the text: as a narrative review, it does not systematically quantify the evidence or conduct meta-analysis, and many cited neuroimaging findings come from small samples that the authors note require replication.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
18 of 65 cited sources checked · 6 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Emotional lability commonly occurs in youth with attention-deficit/hyperactivity disorder.
“Emotional lability, or sudden strong shifts in emotion, commonly occurs in youth with attention-deficit/hyperactivity disorder.”
- Also stated in: § INTRODUCTION · plain
“Although the diagnostic criteria of ADHD include inattention, hyperactivity, and impulsivity, many children with ADHD also demonstrate significant levels of emotional lability [2].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [2] Sobanski E et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010;51(8):915–23. This was one of the first papers to estimate the prevalence of emotional lability. It also related ratings of emotional lability to clinical features. source
- Also stated in: § INTRODUCTION · plain
- Premisecitation
Recent functional neuroimaging studies suggest that anomalies within frontolimbic circuits, which are not typically associated with executive functions, may underlie emotional lability in children with ADHD.
“These studies have consisted of relatively small samples and require replication, but nonetheless, suggest that anomalies within frontolimbic circuits, which are not typically associated with executive functions, may underlie emotional lability in children with ADHD.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [22] Brotman M et al. Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. Am J Psychiatr. 2010;167(1):61. source
The Discussion reports amygdala hyperactivity during face-emotion processing in youths with ADHD, supporting an emotion-processing neural anomaly. But the ADHD group was selected to have no significant irritability or other mood symptoms; the paper does not establish that frontolimbic anomalies underlie emotional lability in children with ADHD or contrast those circuits with executive-function circuits. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [23] Hulvershorn L et al. Abnormal amygdala functional connectivity associated with emotional lability in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013. doi: 10.1016/j.jaac.2013.11.012 . source
The Results (Amygdala IFC and Emotional Lability in ADHD; page unavailable) associate emotional lability in children with ADHD with altered connectivity between the amygdala and prefrontal and other cortical regions. The Discussion suggests that disruptions in these networks may underlie emotion-regulation difficulties. The paper does not establish that the implicated circuits are not typically associated with executive functions; its introductory passage instead describes prefrontal regions as involved in both cognitive and emotional control. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [24] Sonuga-Barke EJ et al. Hyperactivity and delay aversion–I. The effect of delay on choice. J Child Psychol Psychiatry. 1992;33(2):387–98. source
- Premisecitation
Preliminary neuroimaging studies suggest that stimulants may attenuate atypical emotional processing in regions including the amygdala and medial prefrontal cortex and through improvements in the inferior frontal gyrus.
“Neuroimaging studies have only begun to test these competing hypotheses, but preliminary studies suggest that stimulants may attenuate atypical emotional processing in regions associated with emotion including the amygdala and medial prefrontal cortex [3, 27] and through improvements in regions associated with inhibitory control, such as the inferior frontal gyrus [28].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [3] Posner J et al. The attenuation of dysfunctional emotional processing with stimulant medication: an fMRI study of adolescents with ADHD. Psychiatry Res Neuroimaging. 2011. doi: 10.1016/j.pscychresns.2011.02.005 . source
- cites [27] Hulvershorn, L. The impact of methylphenidate on frontal activation in youth with disruptive mood dysregulation disorder, in 60th Annual Meeting of the American Academy of Child and Adolescent Psychiatry 2013; Orlando, FL.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [28] Bradley C, Bowen M. Amphetamine (Benzedrine) therapy of children's behavior disorders. Am J Orthopsychiatry. 1941;11(1):92–103. source
- Premisecitation
Exacerbation of irritability is a reported side effect of stimulant treatment.
“Clinical decision making in regards to emotional lability is complicated by the fact that exacerbation of irritability is a reported side effect of stimulant treatment [42, 43].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [42] Pliszka SR et al. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(5):619–26. source
- cites [43] Blader JC et al. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics. 2010;126(4):e796–806. source
The Results (Tolerability and Adverse Effects; page unavailable) describe adverse-effect monitoring but do not identify exacerbated irritability as a stimulant side effect. The Results (Child Factors Associated With Aggression Outcome; page unavailable) say no child had worsening mood-relevant symptoms on their optimized stimulant regimen. I searched for irritability, worsening, and adverse effects; the study's finding does not establish or rule out whether irritability has been reported as a side effect elsewhere. (LLM, conf=0.73)
Experimental — accuracy not yet measured
- Interpretationcitation
Empirical support for the dyscontrol hypothesis is somewhat lacking.
“Empirical support for the dyscontrol hypothesis, however, is somewhat lacking.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [21] Posner J et al. Dissociable attentional and affective circuits in medication-naïve children with attention-deficit/hyperactivity disorder. Psychiatry Res Neuroimaging. 2013. doi: 10.1016/j.pscychresns.2013.01.004 . source
- Premisecitation
Recent neuropsychological studies have found demonstrable, consistent impairments in sustained focus difficult to demonstrate in ADHD, at least in the laboratory setting.
“The central role of an attentional deficit in ADHD has been questioned by recent neuropsychological studies [21, 26] in which demonstrable, consistent impairments in sustained focus have been difficult to demonstrate, at least in the laboratory setting.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [21] Posner J et al. Dissociable attentional and affective circuits in medication-naïve children with attention-deficit/hyperactivity disorder. Psychiatry Res Neuroimaging. 2013. doi: 10.1016/j.pscychresns.2013.01.004 . source
The Introduction (page unavailable) supports questioning a single attentional explanation of ADHD: it describes a dual-pathway model involving attention and motivation. But it says neuropsychological tasks have demonstrated executive-attention deficits, not that consistent impairments in sustained focus have been difficult to demonstrate in the laboratory. The Discussion likewise reports an association between brain connectivity and executive-attention deficits. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [26] Posner J et al. Abnormal amygdalar activation and connectivity in adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(8):828–37. e3. This neuroimaging-phacmacolgical study suggests that stimulant treatment may normalize hyperactivation of the amygdala in youth with ADHD seen in response to the subliminal presenation of fearful faces. source
The Introduction discusses inattention as a characteristic of ADHD and says the fearful-face task was designed to limit attention differences as a confound. The Method describes an fMRI task, not a test of sustained focus. Searches for sustained-focus impairments and neuropsychological attention findings found no passage addressing whether such impairments are difficult to demonstrate in laboratory studies. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Premisecitation
Most children with ADHD do not manifest impairment on any given executive function measure.
“As Nigg and colleagues [21] have pointed out, most children with ADHD do not manifest impairment on any given executive function measure.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [21] Posner J et al. Dissociable attentional and affective circuits in medication-naïve children with attention-deficit/hyperactivity disorder. Psychiatry Res Neuroimaging. 2013. doi: 10.1016/j.pscychresns.2013.01.004 . source
The Methods (§2.4) describe one executive-attention measure, and the Results (§3.4) report its association with brain connectivity. Neither passage states how many children with ADHD show impairment on any given executive-function measure. Searches for the claimed majority and for percentages of impaired children found no passage addressing that point; the References list names a work coauthored by Nigg but does not report the claim. (LLM, conf=0.72)
Experimental — accuracy not yet measured
- Premisecitation
Emotional lability was found to have a larger effect on patients' overall impairment than hyperactive/impulsive symptoms.
“Moreover, emotional lability was found to have a larger effect on patients’ overall impairment than hyperactive/impulsive symptoms [13].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Spencer T et al. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study. Postgrad Med. 2011;123(5):50. source
The Results section (“Impact of CBCL-DESR on Social Functioning,” page unavailable) reports greater social impairment in children with ADHD who had the deficient emotional self-regulation profile than in other children with ADHD. The paper does not compare the effect of emotional lability with that of hyperactive/impulsive symptoms on overall impairment. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingnone given
Five randomized, double-blind, placebo-controlled trials of stimulant treatment in children or adults with ADHD in which emotional lability or similar constructs was a reported outcome measure have been published.
“Nonetheless, five randomized, double blind, placebo-controlled trials of stimulant treatment in children or adults with ADHD in which emotional lability (or similar constructs) was a reported outcome measure have been published (Table 1).”
Quote in the paperSubstantial claim - Interpretationreasoning
Neurobiological models explaining how stimulant use can improve emotional lability have begun to be tested and suggest mechanisms consistent with both effects on emotion regulatory brain regions and general improvements in inhibitory control regions.
“Neurobiological models explaining how stimulant use can improve emotional lability have begun to be tested and suggest mechanisms consistent with both effects on emotion regulatory brain regions as well as general improvements in inhibitory control regions, which impact emotion as well as cognition.”
Quote in the paperSubstantial claim - Premisecitation
There was no evidence that stimulants worsened either behavioral or cognitive responses in participants with ADHD and anxiety.
“However, there was again no evidence that stimulants worsened either behavioral or cognitive responses in participants with ADHD and anxiety [52].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999;38(4):402–9. source
- Interpretationreasoning
Stimulant treatments for emotional lability appear promising.
“In addition, while stimulant treatments for emotional lability appear promising, there remains a need to address treatment strategies for stimulant refractory youth, to address the issue of treating emotional lability outside of the context of ADHD and to identify evidence-based practices for augmentation agents for partial responders.”
Quote in the paperSubstantial claim - Premisecitation
In a randomized, double-blind, placebo-controlled efficacy study of lisdexamfetamine, Childress et al. reported a significant improvement in emotional lability in LDEX-treated children with ADHD and high levels of emotional lability.
“More recently, in a randomized, double-blind, placebo-controlled efficacy study of lisdexamfetamine (LDEX), Childress et al [40] reported a significant improvement in emotional lability in the LDEX-treated children with ADHD and high levels of emotional lability.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Kavale K. The efficacy of stimulant drug treatment for hyperactivity a meta-analysis. J Learn Disabil. 1982;15(5):280–9. source
- Premisecitation
In Charles Bradley's historic studies of benzedrine, he noted that the children he treated had greater control over the expression of their emotions.
“In Charles Bradley’s historic studies of benzedrine (the first studies documenting stimulants’ beneficial effects in children), he noted that the children he treated had greater “control…over the expression of their emotions” [29].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Kaplan SL. Your child does not have bipolar disorder. Santa Barbara: ABC-CLIO, LLC; 2011. source
- Premisecitation
Several studies from the late 1980s/early 1990s suggested that some children and adolescents with ADHD and comorbid anxiety disorders were less responsive to stimulant treatment than children with ADHD alone for core ADHD symptoms.
“However, several studies from the late 1980s/early 1990s suggested that some children and adolescents with ADHD and comorbid anxiety disorders were less responsive to stimulant treatment than children with ADHD alone, for treatment of core AHDH symptoms [48, 49].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [48] Wolraich ML et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics. 1990;86(1):95–101. source
- cites [49] Martinussen R et al. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(4):377–84. source
- Interpretationnone given
Few concerns for induction of irritability in stimulant-treated youth were raised in the reviewed studies.
“Of note, few concerns for induction of irritability in stimulant treated youth in these studies were raised.”
Quote in the paperSubstantial claim - Premisenone given
Some patients experience increases in irritability and poor frustration tolerance as blood serum levels decline, termed rebound irritability.
“For example, some patients experience increases in irritability and poor frustration tolerance, termed “rebound irritability.””
Quote in the paperSubstantial claim - Premisecitation
In one epidemiologic survey, 30.8% of youth with DMDD also met criteria for ADHD.
“In one epidemiologic survey, 30.8% of youth with DMDD also met criteria for ADHD [9], highlighting the significant overlap between these diagnostic constructs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Stringaris A, Goodman R. Mood lability and psychopathology in youth. Psychol Med. 2009;39(8):1237. source
- Premisecitation
Numerous randomized clinical trials demonstrate stimulants' short-term efficacy on the diagnostic symptoms of ADHD.
“The paucity of empirical support for stimulant effects on emotional lability stands in stark contrast with the numerous, randomized clinical trials demonstrating stimulant’s short term efficacy on the diagnostic symptoms of ADHD [32, 33].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [32] Greenhill L et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93. source
- cites [33] Reimherr FW et al. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93–101. Using a crossover, placebo-controlled design in a sample of 47 adults with ADHD, the authors report large improvements (effect size: 0.7) in emotional dysregulation following treatment with osmotic release oral system methylphenidate. source
- Premisecitation
The effect size for extended-release methylphenidate on emotional lability ranged from 0.28 to 0.4.
“The effect size ranged from 0.28 to 0.4, which is lower than stimulants’ effect size on diagnostic ADHD symptoms (meta-analyses suggest a range of 0.6–0.8 [36, 37]), but it is still clinically significant.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Rosler M et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2010;11(5):709–18. source
- Premisecitation
Children with ADHD and anxiety showed a more pronounced response when treated with methylphenidate combined with behavioral intervention.
“Children with ADHD and anxiety, however, showed a more pronounced response when treated with MPH combined with the behavioral intervention.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Greenhill L et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93. source
- Premisecitation
Clinical experience has long suggested that stimulants can have positive, favorable effects on emotional lability.
“Though debate persists over the neural mechanisms by which stimulants improve emotional lability, clinical experience has long suggested that stimulants can have positive, favorable effects on emotional lability.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [29] Kaplan SL. Your child does not have bipolar disorder. Santa Barbara: ABC-CLIO, LLC; 2011. source
- cites [30] Network UAA. Handbook for attention deficit hyperactivity disorder in adults. Heidelberg: Springer; 2013.
Not checked in the free run.
- cites [31] Group MC. A 14-month randmonized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073–86. source
- Interpretationreasoning
Differing assessment tools and study samples likely contributed to the broad range in prevalence estimates of emotional lability in ADHD.
“Differing assessment tools and study samples have likely contributed to the broad range in prevalence estimates of emotional lability in ADHD.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Empirical support for stimulant effects on emotional lability is less robust than anecdotal support.
“Despite anecdotal support, empirical support for stimulant effects on emotional lability is less robust.”
Quote in the paperSubstantial claim - Premisecitation
Recent work suggests that the majority of parents who report that their child is unable to tolerate stimulant medications due to irritability are misattributing rebound irritability or lack of efficacy to stimulant-induced irritability.
“Recent work suggests that the majority of parents who report that their child is unable to tolerate stimulant medications due to irritability, are misattributing rebound irritability or lack of efficacy to stimulant-induced irritability [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatr. 1991;148(5):564–77. source
- Premisecitation
Meta-analyses suggest that stimulants' effect size on diagnostic ADHD symptoms ranges from 0.6 to 0.8.
“meta-analyses suggest a range of 0.6–0.8 [36, 37]”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] Childress AC et al. The effects of lisdexamfetamine dimesylate on emotional lability in children 6 to 12 years of age with ADHD in a double-blind placebo-controlled trial. J Atten Disord. 2012. doi: 10.1177/1087054712448252 . This is the largest study of stimulant effects on emotional lablity in youth with ADHD and the findings suggest that lisdexamfetamine attenuates this symptom in highly emotional labile youth with ADHD. source
- cites [37] Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;62(9):954–62. source
- Interpretationreasoning
The disparity in empirical support for stimulant effects on emotional lability versus diagnostic ADHD symptoms may partly reflect the lack of reliable assessment instruments for monitoring treatment-related improvements in emotional lability.
“This disparity in empirical support may, to some extent, reflect the lack of reliable assessment instruments for monitoring treatment related improvements in emotional lability.”
Quote in the paperSubstantial claim - Premisecitation
Other placebo-controlled trials of methylphenidate in adults with ADHD report improvements in emotional lability with larger effect sizes of up to 0.7.
“Other placebo-controlled trials of methylphenidate in adults with ADHD similarly report improvements in emotional lability (Table 1) with larger effect sizes of up to 0.7 [38, 39].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [38] Marchant BK et al. Psychometric properties of the Wender-Reimherr adult attention deficit disorder scale. Psychol Assess. 2013;25(3):942–50. source
- cites [39] Schachter HM et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can Med Assoc J. 2001;165(11):1475–88.
- Interpretationnone given
Recent studies, some in adults, have utilized assessment tools capable of valid and reliable monitoring of emotional lability across treatment.
“Recent studies, some in adults, have utilized assessment tools capable of valid and reliable monitoring of emotional lability across treatment.”
Quote in the paperNot a substantial claim - Premisecitation
In a multi-center trial of 363 adults with ADHD, 24 weeks of extended-release methylphenidate produced a significant reduction in emotional lability as assessed by the emotional dysregulation items on the Wender-Reimherr Adult ADHD Scale.
“Following 24 weeks of treatment with extended release methylphenidate (MPH-ER), there was a significant reduction in emotional lability, as assessed by the emotional dysregulation items on the Wender-Reimherr Adult ADHD Scale [35].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Rosler M et al. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2010;11(5):709–18. source
- cites [35] Marchant BK et al. Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms. J Atten Disord. 2011;15(4):295–304. source
- May combine two claims. 24
- Classified as probably not a substantial claim. 14
- The quote only partly states this claim. 1
May combine two claims.
PremisecitationChildren with high levels of emotional lability tolerate frustration poorly, have high levels of irritability, and demonstrate frequent crying spells or tantrums.
“Children with high levels of emotional lability have been shown to tolerate frustration poorly, have high levels of irritability and demonstrate frequent crying spells or tantrums [2].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [2] Sobanski E et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010;51(8):915–23. This was one of the first papers to estimate the prevalence of emotional lability. It also related ratings of emotional lability to clinical features. source
May combine two claims.
PremisecitationThe presence of emotional lability in hyperactive children is associated with more severe ADHD symptoms, more frequent comorbid disorders, and higher rates of substance use disorders.
“Studies have also shown that the presence of emotional lability in hyperactive children is associated with more severe ADHD symptoms, more frequent comorbid disorders, and higher rates of substance use disorders [2, 14, 15].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [2] Sobanski E et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010;51(8):915–23. This was one of the first papers to estimate the prevalence of emotional lability. It also related ratings of emotional lability to clinical features. source
- cites [14] Barkley R. Deficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorder. J ADHD Relat Disord. 2010;1:5–37.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [15] Hinshaw SP. Impulsivity, emotion regulation, and developmental psychopathology: specificity versus generality of linkages. Ann N Y Acad Sci. 2003;1008(1):149–59. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe affectivity hypothesis maintains that emotional lability in children with ADHD emerges through dysfunctional emotional processing itself, with emotional stimuli eliciting inordinately strong emotional responses.
“An opposing hypothesis, which we term the “affectivity hypothesis,” maintains that emotional lability in children with ADHD emerges not from impaired executive functions, but rather through the more direct route of dysfunctional emotional processing itself.”
- Also stated in: § NEUROBIOLOGICAL MODELS OF EMOTIONAL LABILITY IN ADHD · plain
“Emotional stimuli, according to the affectivity hypothesis, elicit inordinately strong emotional responses in children with ADHD [25].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [25] Sonuga-Barke E, Bitsakou P, Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(4):345–55. source
The Introduction and Results discuss inhibitory control, delay aversion, and timing deficits, but do not address the affectivity hypothesis or emotional lability. Searches for emotional processing, emotional stimuli, and strong emotional responses found no passage supporting the attributed claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Also stated in: § NEUROBIOLOGICAL MODELS OF EMOTIONAL LABILITY IN ADHD · plain
May combine two claims.
PremisecitationAdditional studies suggest that comorbid anxiety neither interferes in the response to stimulants on diagnostic symptoms of ADHD nor increases side effects.
“Additional studies suggest that co-morbid anxiety neither interferes in the response to stimulants on diagnostic symptoms of ADHD, nor increases side effects.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [53] Wolraich M et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22. source
The INTRODUCTION discusses stimulant efficacy for ADHD symptoms and lists adverse effects, but does not compare either outcome between children with and without comorbid anxiety. Its discussion of anxiety concerns the benefits of combined behavioral and medication treatment on academic and conduct measures, not whether anxiety changes stimulant response or side effects. Searched for comorbid anxiety, stimulant response, and adverse effects. (LLM, conf=0.73)
Experimental — accuracy not yet measured - cites [32] Greenhill L et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSobanski and colleagues found that in a clinical sample of 1,186 children with ADHD, 25% had severe levels of emotional lability and an additional 50% had moderate levels.
“Based on the emotional lability subscale of the Parent and Teacher Conners’ ADHD rating scale, Sobanski and colleagues [2] found that in a clinical sample of 1186 children with ADHD, 25% had severe levels of emotional lability and an additional 50% had moderate levels.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [2] Sobanski E et al. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence. J Child Psychol Psychiatry. 2010;51(8):915–23. This was one of the first papers to estimate the prevalence of emotional lability. It also related ratings of emotional lability to clinical features. source
The “Distribution and severity of emotional lability” section reports 296 of 1,186 probands (25%) in the severe group and 594 (50%) in the mild/moderate group. The citing sentence calls that entire 50% “moderate,” omitting the paper’s “mild” qualification. Page numbers are not available in the supplied copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTwo competing hypotheses have been advanced to explain the neurobiological bases of emotional lability in ADHD.
“Two competing hypotheses have been advanced to explain the neurobiological bases of emotional lability in ADHD [3, 16, 17].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [3] Posner J et al. The attenuation of dysfunctional emotional processing with stimulant medication: an fMRI study of adolescents with ADHD. Psychiatry Res Neuroimaging. 2011. doi: 10.1016/j.pscychresns.2011.02.005 . source
- cites [16] Sonuga-Barke EJ. Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition. Behav Brain Res. 2002;130(1–2):29–36. source
- cites [17] Barkley R. ADHD and the nature of self-control. New York: Guilford Press; 1997.
Not checked in the free run.
May combine two claims.
PremisecitationAfter controlling for hyperactive/impulsive and inattentive symptoms, emotional lability independently contributed to higher rates of incarceration, poorer academic achievement, more driving accidents, and more problematic social and marital relations.
“After controlling for the influence of hyperactive/impulsive and inattentive symptoms, the study found that emotional lability independently contributed to higher rates of incarceration, poorer academic achievement, more driving accidents, and more problematic poor social and marital relations.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Spencer T et al. Toward defining deficient emotional self-regulation in children with attention-deficit/hyperactivity disorder using the Child Behavior Checklist: a controlled study. Postgrad Med. 2011;123(5):50. source
The Results (Impact of CBCL-DESR on Social Functioning; page unavailable) report poorer peer functioning in children with ADHD and DESR after controlling for comorbid disorders, not after controlling for hyperactive/impulsive and inattentive symptoms. The Results (School and Family Functioning and Treatment History; page unavailable) found no added impairment in school or family functioning, and the Discussion explicitly says the study did not find added academic impairment. Our copy does not report incarceration, driving accidents, or marital outcomes. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationDiamond and colleagues randomized 91 children with ADHD and ADHD plus anxiety to a titration trial of methylphenidate followed by a four-month extended trial; subjects with and without anxiety responded equally well, and there were no differences in side effects between groups.
“Diamond and colleagues [53] randomized 91 children with ADHD and ADHD + anxiety to an acute and clinically applicable titration trial of MPH, followed by a four-month extended trial. Subjects with and without anxiety responded equally well to the stimulant, and there were no differences in side effects between groups.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [53] Wolraich M et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22. source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEmotional lability may be associated with an over-expression of positive emotions such as exuberance, excitability, and energy that are disproportionate to the eliciting circumstance and can be off-putting to peers.
“Emotional lability may also be associated with an over-expression of positive emotions such as exuberance, excitability, and energy that are disproportionate to the eliciting circumstance, and can be off-putting to peers [5, 6].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5] Rydell A-M, Berlin L, Bohlin G. Emotionality, emotion regulation, and adaptation among 5-to 8-year-old children. Emotion. 2003;3(1):30. source
- cites [6] Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims. The quote only partly states this claim.
PremisecitationIn a 12-week, placebo-controlled, double-blinded, crossover trial of 75 boys with ADHD, methylphenidate produced significant reductions in emotional lability on the Conners' Parent and Teacher ADHD rating scale, with effect sizes of 0.42-0.46 for parent reports and 0.45-0.79 for teacher reports.
“Significant reductions in emotional lability were noted on the emotional lability subscale of the Conners’ Parent and Teacher ADHD rating scale. Effect sizes ranged from 0.42–0.46 and 0.45–0.79 for parent and teacher reports, respectively.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41] Biederman J et al. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. Clin Ther. 2007;29(3):450–63. source
May combine two claims.
InterpretationcitationThe effect size of extended-release methylphenidate on emotional lability is lower than stimulants' effect size on diagnostic ADHD symptoms but is still clinically significant.
“The effect size ranged from 0.28 to 0.4, which is lower than stimulants’ effect size on diagnostic ADHD symptoms (meta-analyses suggest a range of 0.6–0.8 [36, 37]), but it is still clinically significant.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA more recent study showed that methylphenidate had moderate beneficial effects on selective aspects of verbal-auditory working memory and on visual-spatial working memory in children with ADHD but showed no such improvements in children with ADHD and anxiety.
“A more recent study showed that MPH had moderate but beneficial effects on selective aspects of verbal–auditory working memory and on a visual-spatial working memory in children with ADHD but showed no such improvements in children with ADHD and anxiety [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1999;38(4):402–9. source
May combine two claims.
PremisecitationTannock and colleagues demonstrated that a single dose of methylphenidate improved verbal-auditory working memory in non-anxious children with ADHD, but had no beneficial effects in those with ADHD and comorbid anxiety.
“Tannock and colleagues [51] demonstrated that even a single dose of MPH improved tasks of verbal–auditory working memory (digit span forward and backward) in non-anxious children with ADHD, whereas there were no beneficial effects on those with ADHD and comorbid anxiety.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Bedard A-C, Tannock R. Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord. 2008;11(5):546–57. source
May combine two claims.
Premisenone givenWithdrawal effects occur toward the end of the stimulant's duration of action, whereas stimulant-induced emotional lability typically occurs as stimulant levels are peaking.
“This typically can be discerned based on the timing of the symptoms – withdrawal effects occur toward the end of the stimulant’s duration of action, whereas stimulant-induced emotional lability typically occurs as stimulant levels are peaking.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationImprovement in emotional lability can be expected for many patients with ADHD, but in a small minority stimulants can induce or worsen emotional lability through increases in irritability.
“Whereas improvement in emotional lability can be expected for many patients with ADHD, in a small minority, stimulants can induce or worsen emotional lability, through increases in irritability.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAccording to the dyscontrol hypothesis, emotional processing is largely normal in children with ADHD, but their capacity to down-regulate or inhibit emotional responses is impaired.
“According to the dyscontrol hypothesis, emotional processing is largely normal in children with ADHD; however, hyperactive children are impaired in their capacity to down-regulate, or inhibit, emotional responses and thus manifest highly emotional behaviors and reactions.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Barkley RA et al. Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol. 2001;29(6):541–56. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe Texas Children's Medication Algorithm Project suggests that if a child has ADHD and anxiety, treatment should begin with either a stimulant or atomoxetine.
“Similarly, the Texas Children’s Medication Algorithm Project (CMAP), a consensus conference that developed treatment algorithms for the pharmacotherapy of ADHD and comorbid conditions, suggests that if a child has ADHD and anxiety, treatment should begin with either a stimulant or atomoxetine (Strattera) [55].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningStimulants' efficacy in reducing the diagnostic symptoms of ADHD has been repeatedly demonstrated, but studies of stimulant effects on emotional lability are far less numerous though suggestive.
“In sum, whereas stimulants’ efficacy in reducing the diagnostic symptoms of ADHD has been repeatedly demonstrated, studies of stimulant effects on emotional lability, though suggestive, are far less numerous.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenFew instruments have been developed for assessing emotional lability, whereas several well-validated parent- and teacher-report instruments are available to assess diagnostic symptoms of ADHD.
“Whereas several well-validated, parent- and teacher-report instruments are available to assess diagnostic symptoms of ADHD, few instruments have been developed for similarly assessing emotional lability.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe reviewed studies are uniformly supportive of stimulant use to treat emotional lability in ADHD, although additional research in youth is needed to validate these findings.
“These studies are uniformly supportive of stimulant use to treat emotional lability in ADHD, although certainly in youth, additional research to validate these findings is needed.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSuch neuroimaging findings are supportive of both the dyscontrol and affectivity hypotheses, suggesting stimulants may have a direct salutary effect on emotional processing regions and on regions traditionally associated with more cognitive functions that may influence emotion regulation.
“Such findings are supportive of both hypotheses, suggesting that stimulants may have a direct salutary effect on emotional processing regions and regions traditionally associated with more cognitive functions, that may influence emotion regulation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe affectivity hypothesis has received less research and clinical focus than the dyscontrol hypothesis, perhaps because ADHD is conceptualized largely as a cognitive or non-affective disorder.
“The affectivity hypothesis has received less research and clinical focus than the dyscontrol hypothesis perhaps because ADHD is conceptualized largely as a cognitive, or non-affective disorder.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMany youth with ADHD also struggle with significant levels of anxiety, and between 20-40% have a comorbid anxiety disorder.
“In addition to emotional lability, many youth with ADHD also struggle with significant levels of anxiety, and between 20 – 40% have a comorbid anxiety disorder [45, 46].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [45] Jensen PS et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–58. source
- cites [46] Schatz DB, Rostain AL. ADHD with comorbid anxiety a review of the current literature. J Atten Disord. 2006;10(2):141–9. source
May combine two claims.
PremisecitationChildren with comorbid anxiety also had higher rates of side effects, including tics, although there was no evidence that stimulants worsened symptoms of either ADHD or anxiety.
“Children with comorbid anxiety also had higher rates of side effects, including tics, although there was no evidence that stimulants worsened symptoms of either ADHD or anxiety.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [48] Wolraich ML et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics. 1990;86(1):95–101. source
- cites [49] Martinussen R et al. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(4):377–84. source
May combine two claims.
PremisecitationIn the Multimodal Treatment Study, 579 children with ADHD were randomized, and children with ADHD and anxiety showed an equally positive response to methylphenidate as those without anxiety.
“Most notably, in the Multimodal Treatment Study (MTA)[32], 579 children with ADHD were randomized to community treatment, intensive behavioral intervention, medication management, or a combination of medication management and behavioral intervention. Children with ADHD and anxiety showed an equally positive response to MPH as those children with ADHD without anxiety [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Greenhill L et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45(11):1284–93. source
May combine two claims.
PremisecitationAnxiety associated with ADHD may emerge from an inability to function in daily life due to the social and cognitive limitations associated with ADHD, and this type of anxiety may differ etiologically from primary anxiety disorder.
“Anxiety associated with ADHD may emerge from an inability to function in daily life due to the social and cognitive limitations associated with ADHD. This type of anxiety may differ etiologically from the worry and phobic behaviors characteristic of a primary anxiety disorder [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28(6):882–7. source
Classified as probably not a substantial claim.
PremisecitationAAP guidelines note that if the diagnosis of ADHD is confirmed, appropriate treatment of ADHD can result in the resolution of comorbid symptoms such as anxiety.
“If the diagnosis of ADHD is confirmed, the AAP guidelines note that appropriate treatment of ADHD can result in the resolution of comorbid symptoms such as anxiety [54].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Pliszka SR et al. The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(6):642–57. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe dyscontrol hypothesis attributes emotional lability in ADHD primarily to impairments in executive control.
“The first, which we have termed the “dyscontrol hypothesis,” attributes emotional lability in ADHD primarily to impairments in executive control [18].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [18] Barkley R. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121(1):65–94. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBecker and colleagues reported that 40-49% of children with ADHD in a clinical sample had elevated levels of parent-reported emotional symptoms similar to emotional lability.
“Using a clinical sample, Becker and colleagues [11] reported a slightly higher rate, with 40–49% of children with ADHD having elevated levels of parent-reported emotional symptoms (symptoms similar to emotional lability).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Strine TW, et al. Emotional and behavioral difficulties and impairments in everyday functioning among children with a history of attention-deficit/hyperactivity disorder. Preventing chronic disease, 2006; 3(2).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn a study of 5,326 children with ADHD, Stringaris and colleagues found that parents reported impairing levels of emotional lability in 38% of the sample.
“In a study of 5,326 children with ADHD, Stringaris and colleagues [10] found that parents reported impairing levels of emotional lability (termed “mood lability” in this study) in 38% of the sample.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Becker A et al. Psychopathological screening of children with ADHD: strengths and difficulties questionnaire in a pan-European study. Eur Child Adolesc Psychiatry. 2006;15(1):i56–62. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenEmotional reactions in ADHD-related emotional lability are typically brief, lasting minutes to hours, and thus differ from emotional lability associated with bipolar spectrum disorders, which have protracted episodes of days to weeks.
“These emotional reactions, both for positive and negative emotions, are typically brief in duration, lasting on the order of minutes to hours, rather than days to weeks, and thus differ from emotional lability associated with bipolar spectrum disorders, which are characterized by protracted episodes (e.g., days-weeks) of low or high emotional states.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationThe dyscontrol hypothesis is parsimonious because impairments in executive functions are well documented in ADHD.
“This is a parsimonious hypothesis in that impairments in executive functions are well documented in ADHD [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Nigg JT et al. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiatry. 2005;57(11):1224–30. source
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The relationship between stimulant treatment and EL in individuals with ADHD remains unclear.
“however the relationship between stimulant treatment and EL in individuals with ADHD remains unclear (Posner et al., 2014).”
From A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials (2024) · cites this paper as Posner et al., 2014
The Stimulant Effects on Emotional Lability section says empirical evidence is limited, and the Stimulant-Induced Irritability section calls for further replication and long-term follow-up (page numbers unavailable). But the Conclusions describe the available studies as uniformly supportive of stimulant treatment for emotional lability. Saying the relationship simply “remains unclear” captures the uncertainty while omitting that consistent positive signal. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Cites
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,154 · see citing works
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,632 · see citing works
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372 · see citing works
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185 · see citing works
Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Sprafkin, J. N., & Carlson, G. A. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1266 · Cited by 1,911 · see citing works
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738 · see citing works
ADHD and The Nature of Self-Control
Barkley, R. A., & Wasserstein, J. (2000) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.14.1.111 · Cited by 1,639 · see citing works
MARTINUSSEN, R., HAYDEN, J., HOGG-JOHNSON, S., & TANNOCK, R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000153228.72591.73 · Cited by 1,297 · see citing works
ADHD and the Nature of Self-Control
Hinshaw, S. P. (1998) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199806000-00010 · Cited by 1,209 · see citing works
ADHD Comorbidity Findings From the MTA Study: Comparing Comorbid Subgroups
JENSEN, P. S., HINSHAW, S. P., KRAEMER, H. C., LENORA, N., NEWCORN, J. H., ABIKOFF, H. B., MARCH, J. S., ARNOLD, L. E., CANTWELL, D. P., CONNERS, C. K., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00009 · Cited by 974 · see citing works
Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition
Sonuga-Barke, E. J. S. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00432-6 · Cited by 901 · see citing works
Nigg, J. T., Willcutt, E. G., Doyle, A. E., & Sonuga-Barke, E. J. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.025 · Cited by 886 · see citing works
Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 3rd ed
Lyon, G. J., & Coffey, B. J. (2008) · The Journal of Clinical Psychiatry · Cited by 755 · see citing works
Defining Clinical Phenotypes of Juvenile Mania
Leibenluft, E., Charney, D. S., Towbin, K. E., Bhangoo, R. K., & Pine, D. S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.430 · Cited by 685 · see citing works
Barkley, R. A., Edwards, G., Laneri, M., Fletcher, K., & Metevia, L. (2001) · Journal of Abnormal Child Psychology · doi:10.1023/a:1012233310098 · Cited by 638 · see citing works
Wehmeier, P. M., Schacht, A., & Barkley, R. A. (2010) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2009.09.009 · Cited by 628 · see citing works
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580 · see citing works
Hyperactivity and Delay Aversion—I. The Effect of Delay on Choice
Sonuga‐Barke, E. J. S., Taylor, E., Sembi, S., & Smith, J. (1992) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1992.tb00874.x · Cited by 578 · see citing works
Sonuga-Barke, E., Bitsakou, P., & Thompson, M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2009.12.018 · Cited by 504 · see citing works
Barkley, R. A., & Fischer, M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.01.019 · Cited by 479 · see citing works
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235077.32661.61 · Cited by 467 · see citing works
Emotionality, emotion regulation, and adaptation among 5- to 8-year-old children.
Rydell, A.-M., Berlin, L., & Bohlin, G. (2003) · Emotion · doi:10.1037/1528-3542.3.1.30 · Cited by 461 · see citing works
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442 · see citing works
ADHD With Comorbid Anxiety: A Review of the Current Literature
Schatz, D. B., & Rostain, A. L. (2006) · Journal of Attention Disorders · doi:10.1177/1087054706286698 · Cited by 407 · see citing works
Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404 · see citing works
(2001) · Europe PMC (PubMed Central) · Cited by 393 · see citing works
Prevalence, Comorbidity, and Correlates of DSM-5 Proposed Disruptive Mood Dysregulation Disorder
Copeland, W. E., Angold, A., Costello, E. J., & Egger, H. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010132 · Cited by 391 · see citing works
Sobanski, E., Banaschewski, T., Asherson, P., Buitelaar, J., Chen, W., Franke, B., Holtmann, M., Krumm, B., Sergeant, J., Sonuga‐Barke, E., et al. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02217.x · Cited by 365 · see citing works
Brotman, M. A., Rich, B. A., Guyer, A. E., Lunsford, J. R., Horsey, S. E., Reising, M. M., Thomas, L. A., Fromm, S. J., Towbin, K., Pine, D. S., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09010043 · Cited by 322 · see citing works
Tannock, R., Ickowicz, A., & Schachar, R. J. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199507000-00012 · Cited by 301 · see citing works
Effect of Anxiety on Cognition, Behavior, and Stimulant Response in ADHD
PLISZKA, S. R. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198911000-00012 · Cited by 293 · see citing works
(2006) · Europe PMC (PubMed Central) · Cited by 216 · see citing works
Reimherr, F. W., Williams, E. D., Strong, R. E., Mestas, R., Soni, P., & Marchant, B. K. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0113 · Cited by 180 · see citing works
Wolraich, M. L., Lindgren, S., Stromquist, A., Milich, R., Davis, C., & Watson, D. (1990) · Pediatrics · doi:10.1542/peds.86.1.95 · Cited by 170 · see citing works
Coghill, D. R., Rhodes, S. M., & Matthews, K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.030 · Cited by 170 · see citing works
Mood lability and psychopathology in youth
Stringaris, A., & Goodman, R. (2009) · Psychological Medicine · doi:10.1017/s0033291708004662 · Cited by 162 · see citing works
The Efficacy of Stimulant Drug Treatment for Hyperactivity: A Meta-Analysis
Kavale, K. (1982) · Journal of Learning Disabilities · doi:10.1177/002221948201500508 · Cited by 152 · see citing works
Hulvershorn, L. A., Mennes, M., Castellanos, F. X., Di Martino, A., Milham, M. P., Hummer, T. A., & Roy, A. K. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.012 · Cited by 138 · see citing works
Self-citationPosner, J., Nagel, B. J., Maia, T. V., Mechling, A., Oh, M., Wang, Z., & Peterson, B. S. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.05.010 · Cited by 137 · see citing works
Self-citationResponse to Methylphenidate in Children With ADHD and Comorbid Anxiety
DIAMOND, I. R., TANNOCK, R., & SCHACHAR, R. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199904000-00012 · Cited by 132 · see citing works
Rösler, M., Retz, W., Fischer, R., Ose, C., Alm, B., Deckert, J., Philipsen, A., Herpertz, S., & Ammer, R. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622971003624197 · Cited by 131 · see citing works
PLISZKA, S. R., BROWNE, R. G., OLVERA, R. L., & WYNNE, S. K. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200005000-00016 · Cited by 130 · see citing works
Spencer, T. J., Faraone, S. V., Surman, C. B. H., Petty, C., Clarke, A., Batchelder, H., Wozniak, J., & Biederman, J. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2459 · Cited by 127 · see citing works
Amphetamine (benzedrine) therapy of children's behavior disorders.
Bradley, C., & Bowen, M. (1941) · American Journal of Orthopsychiatry · doi:10.1111/j.1939-0025.1941.tb05781.x · Cited by 115 · see citing works
Stimulant-Responsive and Stimulant-Refractory Aggressive Behavior Among Children With ADHD
Blader, J. C., Pliszka, S. R., Jensen, P. S., Schooler, N. R., & Kafantaris, V. (2010) · Pediatrics · doi:10.1542/peds.2010-0086 · Cited by 106 · see citing works
Becker, A., Steinhausen, H.-C., Baldursson, G., Dalsgaard, S., Lorenzo, M. J., Ralston**, S. J., Döpfner, M., Rothenberger, A., & ADORE Study Group* (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-1008-7 · Cited by 104 · see citing works
Posner, J., Maia, T. V., Fair, D., Peterson, B. S., Sonuga-Barke, E. J., & Nagel, B. J. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.02.005 · Cited by 104 · see citing works
Self-citationHinshaw, S. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1301.016 · Cited by 103 · see citing works
Posner, J., Rauh, V., Gruber, A., Gat, I., Wang, Z., & Peterson, B. S. (2013) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.01.004 · Cited by 94 · see citing works
Self-citationAnxiety, Methylphenidate Response, and Working Memory in Children With ADHD
Bedard, A.-C., & Tannock, R. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707311213 · Cited by 76 · see citing works
Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.
Marchant, B. K., Reimherr, F. W., Robison, D., Robison, R. J., & Wender, P. H. (2013) · Psychological Assessment · doi:10.1037/a0032797 · Cited by 63 · see citing works
Methylphenidate Transdermal System in Adult ADHD and Impact on Emotional and Oppositional Symptoms
Marchant, B. K., Reimherr, F. W., Robison, R. J., Olsen, J. L., & Kondo, D. G. (2011) · Journal of Attention Disorders · doi:10.1177/1087054710365986 · Cited by 51 · see citing works
Childress, A. C., Arnold, V., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R., & Lopez, F. A. (2014) · Journal of Attention Disorders · doi:10.1177/1087054712448252 · Cited by 33 · see citing works
Handbook for Attention Deficit Hyperactivity Disorder in Adults
Kings College London (2013) · doi:10.1007/978-1-908517-79-1 · Cited by 13 · see citing works
Williamson, G., & Althoff, R. R. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.05.008 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Barkley R. Deficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorder. J ADHD Relat Disord. 2010;1:5–37.
Cited by
Sorted by citations
Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis
Beheshti, A., Chavanon, M.-L., & Christiansen, H. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-2442-7 · Cited by 247 · see citing works
Coghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., et al. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01871-x · Cited by 180 · see citing works
Lenzi, F., Cortese, S., Harris, J., & Masi, G. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.010 · Cited by 141 · see citing works
Moukhtarian, T. R., Cooper, R. E., Vassos, E., Moran, P., & Asherson, P. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.05.021 · Cited by 56 · see citing works
Arnold, V. K., López, F. A., Childress, A. C., Po, M. D., Uchida, C. L., Cuthbertson, L., Sallee, F. R., & Incledon, B. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241243155 · Cited by 1 · see citing works
“…emotions and make individuals more irritable, with irritability contributing to the onset and worsening of EL; this can however be altered by changing a patient’s medication formulation (Ahmann et al., 1993; Gillberg et al., 1997; Kratochvil et al., 2007; Perwien et al., 2008; Posner et al., 2014).”
- Authors
- Posner, J., Kass, E., & Hulvershorn, L.
- Affiliations
- New York State Psychiatric Institute (US)
- Columbia University (US)
- Indiana University School of Medicine (US)
- Corresponding author
- Hulvershorn, Leslie
- Venue
- Current psychiatry reports
- Published
- 2014-08-19
- Volume
- 16
- Issue
- 10
- Pages
- 478-478
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- PMC
- PMC4243526
- OpenAlex
- W1998193363
- Semantic Scholar
- 07b8fd06cbd158268901f85b651e16e16d57a71d
- Cited by
- 66
- References
- 56
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 10 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 3 · 2014: 1
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- PMC
- Funders
- National Institute of Mental Health (K23 MH091249, R01MH101172)
- National Institute on Drug Abuse (K12 DA000357)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- emotional lability, attention deficit hyperactivity disorder, stimulant medication, emotion regulation, neurocognitive model, psychiatric comorbidity, treatment selection
- MeSH terms
- Adolescent, Affective Symptoms, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Brain, Child, Humans, Comorbidity, Mood Disorders, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-27.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-27.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review